83.2 F
New York
Friday, May 24, 2024

An ALS Drug Fails Again (AMLX)

BusinessAn ALS Drug Fails Again (AMLX)

Young cerebral palsy patient

funky-data/E+ via Getty Images

Two years ago, I wrote here about a new drug that was up for approval for ALS patients (who sadly have very few therapeutic options at all). The drug (Relyvrio, a mixture of sodium phenylbutyrate and taurursodiol) had been put through

Source link

Check out our other content

Check out other tags:

Most Popular Articles